Volume 4, Issue 3 ( Journal of Clinical and Basic Research (JCBR) 2020)                   jcbr 2020, 4(3): 15-28 | Back to browse issues page


XML Print


1- Student Research Committee, Golestan University of Medical Sciences, Gorgan, Iran
2- Student Research Committee, Babol University of Medical Sciences, Babol, Iran
3- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
4- Student Research Committee, Tehran University of Medical Sciences, Tehran, Iran
5- Gorgan Congenital Malformations Research Center, Golestan University of Medical Sciences, Gorgan, Iran
Abstract:   (2651 Views)
Background and objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the seventh member of the coronavirus family to infect humans. The coronavirus disease was first identified in late 2019 in Wuhan, China. More than five million people in different countries have been infected with the virus in a matter of months. Although many studies have been done on the molecular immune pathogenesis and genetics of SARS-CoV-2, there is still not enough information about the virus. The purpose of this study is to summarize the latest information on SARS-CoV-2 characteristics, transmission, prevention and management to increase awareness and stop the virus transmission cycle.
Conclusion: The incidence of post-tonsillectomy hemorrhage, the methods for its management and the need for re-admission are quite different in different age groups.
Full-Text [PDF 692 kb]   (1219 Downloads) |   |   Full-Text (HTML)  (705 Views)  
Article Type: Research | Subject: Basic medical sciences

References
1. Christian MD, Poutanen SM, Loutfy MR, Muller MP, Low DE. Severe acute respiratory syndrome. Clinical infectious diseases. 2004;38(10):1420-7. [View at Publisher] [DOI] [PubMed] [Google Scholar]
2. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. The Lancet. 2015;386(9997):995-1007. [View at Publisher] [DOI] [PubMed] [Google Scholar]
3. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. The Lancet. 2020;395(10223):470-3. [View at Publisher] [DOI] [PubMed] [Google Scholar]
4. Zumla A, Chan JF, Azhar EI, Hui DS, Yuen K-Y. Coronaviruses-drug discovery and therapeutic options. Nature reviews Drug discovery.2016;15(5):327. [View at Publisher] [DOI] [PubMed] [Google Scholar]
5. Worldmeter, COVID-19 cronavirus pandemis, retrived from: https://www.worldometers.info/coronavirus, (last updated September 14, 2020)
6. Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, et al. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020;12(4):372. [View at Publisher] [DOI] [PubMed] [Google Scholar]
7. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature. 2020;579(7798):270-3. [View at Publisher] [DOI] [PubMed] [Google Scholar]
8. Zhang T, Wu Q, Zhang Z. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Current Biology. 2020. [View at Publisher] [DOI] [PubMed] [Google Scholar]
9. Adams MJ, Carstens E. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012). Archives of virology. 2012;157(7):1411-22. [View at Publisher] [DOI] [PubMed] [Google Scholar]
10. Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nature reviews microbiology. 2009;7(6):439-50. [View at Publisher] [DOI] [PubMed] [Google Scholar]
11. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New England Journal of Medicine. 2020. [View at Publisher] [PubMed] [Google Scholar]
12. Bai Y, Yao L, Wei T, Tian F, Jin D-Y, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19. Jama. 2020;323(14):1406-7. [View at Publisher] [DOI] [PubMed] [Google Scholar]
13. Fekrazad R. Photobiomodulation and Antiviral Photodynamic Therapy as a Possible Novel Approach in COVID-19 Management. Mary Ann Liebert, Inc., publishers 140 Huguenot Street, 3rd Floor New …; 2020. [View at Publisher] [DOI] [PubMed] [Google Scholar]
14. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 infection in children. New England Journal of Medicine. 2020. [View at Publisher] [DOI] [PubMed] [Google Scholar]
15. Zaman S, MacIsaac AI, Jennings GL, Schlaich M, Inglis SC, Arnold R, et al. Cardiovascular disease and COVID-19: Australian/New Zealand consensus statement. The Medical Journal of Australia. 2020:1. [View at Publisher] [DOI] [PubMed] [Google Scholar]
16. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi-Zoccai G, et al. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. Journal of the American College of Cardiology.2020. [View at Publisher] [DOI] [PubMed] [Google Scholar]
17. Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, et al. Structure of Mpro from COVID-19 virus and discovery of its inhibitors. bioRxiv. 2020. [DOI] [PubMed] [Google Scholar]
18. Walls AC, Park Y-J, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020. [View at Publisher] [DOI] [PubMed] [Google Scholar]
19. Wang J, Wen J, Li J, Yin J, Zhu Q, Wang H, et al. Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus. Clinical Chemistry. 2003;49(12):1989-96. [View at Publisher] [DOI] [PubMed] [Google Scholar]
20. Devaux CA, Rolain J-M, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? International journal of antimicrobial agents. 2020:105938. [View at Publisher] [DOI] [PubMed] [Google Scholar]
21. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19). Statpearls [internet]: StatPearls Publishing; 2020. [View at Publisher] [PubMed] [Google Scholar]
22. Angeletti S, Benvenuto D, Bianchi M, Giovanetti M, Pascarella S, Ciccozzi M. COVID‐2019: the role of the nsp2 and nsp3 in its pathogenesis. Journal of medical virology. 2020. [View at Publisher] [DOI] [PubMed] [Google Scholar]
23. Asselta R, Paraboschi EM, Mantovani A, Duga S. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. 2020. [View at Publisher] [DOI] [PubMed] [Google Scholar]
24. Dhama K, Sharun K, Tiwari R, Dadar M, Malik YS, Singh KP, et al. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Human Vaccines & Immunotherapeutics. 2020:1-7. [View at Publisher] [DOI] [PubMed] [Google Scholar]
25. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. Journal of virology. 2020;94(7). [View at Publisher] [DOI] [PubMed] [Google Scholar]
26. Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. Journal of medical virology. 2020;92(4):418-23. [View at Publisher] [DOI] [PubMed] [Google Scholar]
27. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research. 2020. [View at Publisher] [DOI] [PubMed] [Google Scholar]
28. Kakodkar P, Kaka N, Baig M. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19). Cureus. 2020;12(4). [View at Publisher] [DOI] [PubMed] [Google Scholar]
29. Bushmaker T, Morris D, Holbrook M, Gamble A, Williamson B, Tamin A, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. The New England journal of medicine. 2020. [View at Publisher] [PubMed] [Google Scholar]
30. Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know. American journal of obstetrics and gynecology. 2020. [View at Publisher] [DOI] [PubMed] [Google Scholar]
31. Kakimoto K, Kamiya H, Yamagishi T, Matsui T, Suzuki M, Wakita T. Initial investigation of transmission of COVID-19 among crew members during quarantine of a cruise ship-Yokohama, Japan, February 2020. Morbidity and Mortality Weekly Report. 2020. [View at Publisher] [DOI] [PubMed] [Google Scholar]
32. Mukhtar F, Mukhtar N. Coronavirus (COVID-19): Let's Prevent Not Panic. Journal of Ayub Medical College Abbottabad. 2020;32(1):141-4. [PubMed] [Google Scholar]
33. Wu YC, Chen CS, Chan YJ. The outbreak of COVID-19: An overview. J Chin Med Assoc.2020;83(3):217-20. [View at Publisher] [DOI] [PubMed] [Google Scholar]
34. Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. Jama. 2020;323(16):1582-9. [View at Publisher] [DOI] [PubMed] [Google Scholar]
35. Mecenas P, Bastos R, Vallinoto A, Normando D. Effects of temperature and humidity on the spread of COVID-19: A systematic review. medRxiv. 2020. [View at Publisher] [DOI] [PubMed] [Google Scholar]
36. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine. 2020. [View at Publisher] [DOI] [PubMed] [Google Scholar]
37. Eccles R. Understanding the symptoms of the common cold and influenza. The Lancet infectious diseases. 2005;5(11):718-25. [View at Publisher] [DOI] [PubMed] [Google Scholar]
38. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061-9. [View at Publisher] [DOI] [PubMed] [Google Scholar]
39. Moein ST, Hashemian SM, Mansourafshar B, Khorram‐Tousi A, Tabarsi P, Doty RL, editors. Smell dysfunction: a biomarker for COVID‐19. International Forum of Allergy & Rhinology; 2020: Wiley Online Library. [View at Publisher] [DOI] [PubMed] [Google Scholar]
40. Gautier JF, Ravussin Y. A New Symptom of COVID‐19: Loss of Taste and Smell. Obesity.2020. https://doi.org/10.1002/oby.22809 [DOI] [PubMed] [Google Scholar]
41. Lim J, Jeon S, Shin H-Y, Kim MJ, Seong YM, Lee WJ, et al. Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored byk [View at Publisher] [PubMed] [Google Scholar]
42. quantitative RT-PCR. Journal of Korean medical science. 2020;35(6). [View at Publisher] [PubMed] [Google Scholar]
43. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv [View at Publisher] [PubMed] [Google Scholar]
44. W, et al. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020:200642. [View at Publisher] [PubMed] [Google Scholar]
45. Cheng Z, Lu Y, Cao Q, Qin L, Pan Z, Yan F, et al. Clinical features and chest CT manifestations of coronavirus disease 2019 (COVID-19) in a single-center study in Shanghai, China. American Journal of Roentgenology.2020:1-6. [View at Publisher] [DOI] [PubMed] [Google Scholar]
46. Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, et al. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis. Journal of medical virology. 2020. [View at Publisher] [DOI] [PubMed] [Google Scholar]
47. Zhang Y, Odiwuor N, Xiong J, Sun L, Nyaruaba RO, Wei H, et al. Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP. medRxiv. 2020. [View at Publisher] [DOI] [Google Scholar]
48. Li H, Liu S-M, Yu X-H, Tang S-L, Tang C-K. Coronavirus disease 2019 (COVID-19): current status and future perspective. International Journal of Antimicrobial Agents. 2020:105951. [View at Publisher] [DOI] [PubMed] [Google Scholar]
49. Jin Y-H, Cai L, Cheng Z-S, Cheng H, Deng T, Fan Y-P, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military Medical Research.2020;7(1):4. [View at Publisher] [DOI] [PubMed] [Google Scholar]
50. Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. Journal of medical virology. 2020;92(4):424-32. [View at Publisher] [DOI] [PubMed] [Google Scholar]
51. Deng X, van Geelen A, Buckley AC, O'Brien A, Pillatzki A, Lager KM, et al. Coronavirus endoribonuclease activity in porcine epidemic diarrhea virus suppresses type I and type III interferon responses. Journal of virology.2019;93(8):e02000-18. [View at Publisher] [DOI] [PubMed] [Google Scholar]
52. Keicho N, Itoyama S, Kashiwase K, Phi NC, Long HT, Van Ban V, et al. Association of [View at Publisher] [PubMed] [Google Scholar]
53. human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population. Human immunology. 2009;70(7):527-31. [View at Publisher] [DOI] [PubMed] [Google Scholar]
54. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet respiratory medicine.2020;8(4):420-2. [View at Publisher] [DOI] [PubMed] [Google Scholar]
55. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506. [View at Publisher] [DOI] [PubMed] [Google Scholar]

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.